Mosaic Biosciences, a newly formed subsidiary of The Mosaic Co., aims to improve nutrient use efficiency in agriculture. The platform integrates biological solutions and scientific research to develop advanced crop-input technologies for farmers. This expansion strengthens Mosaic’s agribusiness portfolio with data-driven innovations.
The Mosaic Company launches **Mosaic Biosciences**, a new platform focused on advancing plant health through science and innovation. The initiative integrates technologies designed to improve crop health and leverage natural plant and soil biology to optimize field yield potential. This expansion aims to strengthen Mosaic’s presence in the global agriculture market.
Mosaic acquires Plant Response to strengthen its soil health initiatives. The startup, based in Research Triangle Park, focuses on plant-based solutions to improve agricultural soil conditions. Mosaic, a major supplier of fertilizer and crop nutrients, aims to integrate Plant Response’s expertise into its broader sustainability efforts.
Plant Response acquires Pathway BioLogic to strengthen its agricultural biologicals offerings. The move integrates Pathway BioLogic’s applied microbial science expertise into Plant Response’s portfolio of biological products for farming. This acquisition supports the joint venture’s focus on expanding its ag-biological solutions.
Plant Response Biotech and Koch Biological Solutions have merged operations to create **Plant Response Biotech, Inc.** The new entity consolidates their combined expertise, assets, and product portfolios in agricultural biotechnology. The joint venture aims to integrate their respective strengths in crop protection and biological solutions.
PlantResponse Biotech secures **$6.9 million in Series B funding** from investors including Yara Germinate, iSelect, Bayer Ventures, Middleland Capital, and Novozymes. The company expands operations with a new **North American headquarters in Research Triangle Park, North Carolina**, to drive global growth. The funding supports commercial scaling of its biotech solutions for crop inputs.